Strona główna

  • Banner

  • Reduced price
Development of New MDR-Tuberculosis Drugs

Development of New MDR-Tuberculosis Drugs

9781616682330
258,24 zł
232,41 zł Save 25,83 zł Tax included
Lowest price within 30 days before promotion: 232,41 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
The emergence of resistance to anti-tuberculosis drugs, particularly of MDR-TB and newly XDR-TB, has become a major public health problem. The current treatment regiment has several disadvantages, i.e. long treatment period (DOTS takes minimum 6 months) during which tubercle bacilli mutant become resistant to one or more drugs; side effects of the used drugs; co-infection of HIV/AIDS. The emergence of MDR-TB has made many currently available anti-TB drugs ineffective. Sleeping latent forms of mutant bacilli resistant against common anti-TB drugs pose the risk of epidemic for the new generation. This book outlines the recent advances in the development of new multi-drug-resistant tuberculosis (MDR-TB) drugs.
Product Details
Nova Science Publishers Inc
73408
9781616682330
9781616682330

Data sheet

Rok wydania
2010
Numer wydania
1
Oprawa
miękka foliowana
Wymiary (mm)
230.00 x 155.00
Waga (g)
186
  • Introduction; Resistance to Commonly Used Drugs, Mechanism of the Action; Research of Novel MDR Potential Drugs; Conclusion; Index.
Comments (0)
Viewed products

  • Frequently purchased together

    No products available